Formo Funding: $111M Raised, Series B (2024)

Formo funding overview

Formo is a Biotech company based in Berlin, Germany. Formo has raised $111M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for Formo runs through 2024; nothing later has been disclosed. Investors on record include Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures and 15 others. 21 distinct backers are named across the disclosed rounds.

Formo at a glance

Total raised: $111M
Latest round: Series B
Latest round date: September 2024
Industry: Biotech
Headquarters: Berlin, Germany
Notable investors: Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures, Grazia Capital, Sazaby League

Frequently asked about Formo funding

How much has Formo raised?: Formo has raised $111M in total disclosed funding across the rounds on record.
Who has invested in Formo?: Foodlabs, EQT Ventures, Lowercarbon Capital, Happiness Capital, Elevat3 Capital, M Ventures are named among the investors backing Formo.
What was the latest Formo funding round?: The most recent disclosed round is a Series B, announced in September 2024.
Where is Formo based?: Formo is based in Berlin, Germany.
What sector does Formo operate in?: Formo is tracked under Biotech from Berlin, Germany, with $111M in disclosed funding.
When did Formo last raise?: The last disclosed Formo round closed in September 2024 at Series B.

Formo totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Berlin below to benchmark round size and investor mix.

Formo Funding: $111M Raised, Series B (2024)

Formo funding overview

Formo at a glance

Frequently asked about Formo funding

Formo founders (1)

Companies related to Formo (37)

Browse related funding lists (8)